Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
Saved in:
| Title: | Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation. |
|---|---|
| Authors: | Sokolenko, Anna1,2 (AUTHOR), Preobrazhenskaya, Elena1 (AUTHOR), Marchetti, Claudia3,4 (AUTHOR), Piermattei, Alessia3 (AUTHOR), Zagrebin, Fedor1 (AUTHOR), Kuligina, Ekatherina1 (AUTHOR), Gorodnova, Tatiana1 (AUTHOR), Pavone, Matteo3,4 (AUTHOR), Ivantsov, Alexandr1 (AUTHOR), Bizin, Ilya1 (AUTHOR), Scambia, Giovanni3,4 (AUTHOR), Berlev, Igor1 (AUTHOR), Fagotti, Anna3,4 (AUTHOR), Imyanitov, Evgeny1,2 (AUTHOR) |
| Source: | Pathobiology. 2024, Vol. 91 Issue 2, p108-113. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10152008 |
|---|---|
| DOI: | 10.1159/000533591 |
